Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 12:34 PM
Ignite Modification Date: 2025-12-24 @ 12:34 PM
NCT ID: NCT05069961
Eligibility Criteria: Inclusion Criteria: * 18 years or older * Radiological evidence of 3 or more rib fractures * Within 48 hours of admission to hospital with rib fractures * Can actively participate by answering questions during TEA or ESPB placement * Moderate-severe (4-10 out of 10) pain at the time of enrollment Exclusion Criteria: * Greater than 48 hrs since admission to the hospital with rib fractures * Patient refusal * Prisoner * Infection at the site of TEA or ESPB insertion * Allergy to local anesthetics * Depth from skin to catheter placement target 6 or more centimeters * Greater than 7 consecutive ribs involved on each side * Other regional or epidural block already received * Unable to follow commands/altered mental status * Dementia * Sepsis (temperature \> 38 degrees Celsius \& positive blood cultures) * Elevated intracranial pressure (ICP \> 12 mm Hg) * Coagulopathy (INR \> 1.4) or recent therapeutic anticoagulant use (varies with which medication the patient is on) * Preexisting central nervous system disorders, such as multiple sclerosis * Thrombocytopenia (Platelets \<70,000) * Spine fracture or previous back surgery * Preload dependent states (aortic stenosis, hypertrophic obstructive cardiomyopathy) * Aortic transection * Hemodynamic instability (patients with MAPs \<60 and/or patients requiring pressor support) * Tattoo at sight of catheter placement
Healthy Volunteers: True
Sex: ALL
Minimum Age: 18 Years
Study: NCT05069961
Study Brief:
Protocol Section: NCT05069961